Netherlands· NL-a655741bfc55
Polaramine, tabletten 2 mg
A dexchlorpheniramine product containing dexchloorfeniramine waterstofmaleaat, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Dexchlorpheniramine is registered in 5 of 19 countries.
Countries holding a registration under ATC R06AB02 (dexchlorpheniramine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Dexchlorpheniramine · ATC R06AB02
5 / 19 countries
- Finlandprice
- Franceprice
- Netherlands
- Norwayprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DEXCHLOORFENIRAMINE WATERSTOFMALEAAT
- Manufacturer
- Bayer B.V.
- Country
- Netherlands (NL)
- ATC code
- R06AB02
- ATC class
- Dexchlorpheniramine
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id01848
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexchlorpheniramine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAniraminOrifarm Generics A/S
- SpainPOLARAMINE 2 mg COMPRIMIDOSLaboratorios Farmaceuticos Rovi S.A.
- FrancePOLARAMINE 2 mg, comprimé sécableBAYER HEALTHCARE
- United StatesCorphenaBluCrest Pharmaceuticals LLC
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Spain · Dexclorfeniramina Maleato Accord, Polaramine
- France · Polaramine
- Italy · Polaramin
- Norway · Aniramin, Dexchlorpheniramine Maleate Accord
- Portugal · Dexclorofeniramina Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42ba11a3-e82c-4392-926f-2a9a2271e791 GET /v1/drugs/42ba11a3-e82c-4392-926f-2a9a2271e791?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h01848_smpc.pdf",
"strength": null,
"atc_label": "Dexchlorpheniramine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg01848",
"excipients": [
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"MAÏSZETMEEL, GEPREGELATINEERD"
],
"substances": [
"DEXCHLOORFENIRAMINE WATERSTOFMALEAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h01848.pdf",
"authorised_at": "1990/03/26",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "01848",
"additional_monitoring": "N"
}See everything about dexchlorpheniramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.